Historical Advocacy Activities
- Make comments to the FDA Now on the Draft Guidance (2/10/2020)
- Update on FDA Draft Guidance Statement (12/20/2019)
- Submit Comments to the NEW draft guidance submitted by the FDA (12/5/2019)
- Submit Comments through AFHC Voter Voice
- Submit Comments to The Department of Health and Human Services (3/13/2019)
- NCH Response to the FDA (May 15, 2018)
- Take Action and Contact Legislators by April 16 (April 10, 2018)
- FDA Comment Period Extended (March 21, 2018)
- Letter to FDA on Draft Homeopathic Guidance by Senator Orrin G. Hatch
- Congressional Letter to FDA on the Draft Guidance by Representative Ryan Costello
- Contact Your Legislators – FDA Guidance (March 13, 2018)
- Grassroots Campaign – CO, PA, UT, NM, WA (February 2, 2018)
- FDA Guidance Issue (January 31, 2018)
- AIH: Letter to FTC in Response to Statement on Homeopathy (November 16, 2016)
- AIH Open Letter about Teething Tablets
- AAHP Encourages Clear and Open Communication on Teething Medicines Tragedies
- FTC Issues Enforcement Policy Statement Regarding Marketing Claims for Over-the-Counter Homeopathic Drugs (November 15, 2016)
- NCH ACTION ALERT: Help Us Correct Misconceptions About Homeopathic Teething Tablets (October 17, 2016)
- FDA Warns Against the Use of Homeopathic Teething Tablets and Gels (September 30, 2016)
- FTC Public Workshop: (September 21, 2015)
- FDA Public Hearing: (April 20-21, 2015)
